The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia
Open accessAbstract
Differentiating agents have been proposed to overcome the impaired cellular differentiation in acute myeloid leukemia (AML). However, only the combinations of all-trans retinoic acid or arsenic trioxide with chemotherapy have been successful, and only in treating acute promyelocytic leukemia (also called AML3). We show that iron homeostasis is an effective target in the treatment of AML. Iron chelating therapy induces the differentiation of leukemia blasts and normal bone marrow precursors into monocytes/macrophages in a manner involving modulation of reactive oxygen species expression and the activation of mitogen-activated protein kinases (MAPKs). 30% of the genes most strongly induced by iron deprivation are also targeted by vitamin D3 (VD), a well known differentiating agent. Iron chelating agents induce expression and phosphorylation of the VD receptor (VDR), and iron deprivation and VD act synergistically. VD magnifies activation of MAPK JNK and the induction of VDR target genes. When used to treat one AML patient refractory to chemotherapy, the combination of iron-chelating agents and VD resulted in reversal of pancytopenia and in blast differentiation. We propose that iron availability modulates myeloid cell commitment and that targeting this cellular differentiation pathway together with conventional differentiating agents provides new therapeutic modalities for AML.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Through a comparable pathway, cellular superoxide generation can increase after exposure to iron chelators [48,49].”
From Asbestos and Iron (2023) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Chou, T.-C., & Talalay, P. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90007-4 · Cited by 7,178
Bennett, J. M., Catovsky, D., Mt, D., Flandrin, G., Galton, D. A. G., Gralnick, H. R., & Sultan, C. (1976) · British Journal of Haematology · doi:10.1111/j.1365-2141.1976.tb03563.x · Cited by 5,595
Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases
Johnson, G. L., & Lapadat, R. (2002) · Science · doi:10.1126/science.1072682 · Cited by 4,295
Norman, A. W. (1979) · Cited by 3,769
Cellular response to oxidative stress: Signaling for suicide and survival*
Martindale, J. L., & Holbrook, N. J. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10119 · Cited by 2,314
FoxOs Are Critical Mediators of Hematopoietic Stem Cell Resistance to Physiologic Oxidative Stress
Tothova, Z., Kollipara, R., Huntly, B. J., Lee, B. H., Castrillon, D. H., Cullen, D. E., McDowell, E. P., Lazo-Kallanian, S., Williams, I. R., Sears, C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.01.003 · Cited by 1,562
Vitamin D signalling pathways in cancer: potential for anticancer therapeutics
Deeb, K. K., Trump, D. L., & Johnson, C. S. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2196 · Cited by 1,419
The oxidative environment and protein damage
Davies, M. J. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.08.007 · Cited by 1,392
Löwenberg, B., Downing, J. R., & Burnett, A. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909303411407 · Cited by 1,283
Acute promyelocytic leukemia: from highly fatal to highly curable
Wang, Z., & Chen, Z. (2008) · Blood · doi:10.1182/blood-2007-07-102798 · Cited by 1,282
Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3.
Abe, E., Miyaura, C., Sakagami, H., Takeda, M., Konno, K., Yamazaki, T., Yoshiki, S., & Suda, T. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.8.4990 · Cited by 1,020
High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia
Löwenberg, B., Ossenkoppele, G. J., van Putten, W., Schouten, H. C., Graux, C., Ferrant, A., Sonneveld, P., Maertens, J. A., Jongen‐Lavrencic, M., von Lilienfeld‐Toal, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901409 · Cited by 828
Reactive oxygen species prime Drosophila haematopoietic progenitors for differentiation
Owusu-Ansah, E., & Banerjee, U. (2009) · Nature · doi:10.1038/nature08313 · Cited by 742
Daniels‐Wells, T. R., Delgado, T., Rodríguez, J. A., Helguera, G. F., & Penichet, M. L. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.06.010 · Cited by 646
G ENETICS OF M YELOID L EUKEMIAS
Kelly, L. M., & Gilliland, D. G. (2002) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.3.032802.115046 · Cited by 541
Transferrin receptors in human tissues: their distribution and possible clinical relevance.
Gatter, K. C., Brown, G., Trowbridge, I. S., Woolston, R.-E., & Mason, D. Y. (1983) · Journal of Clinical Pathology · doi:10.1136/jcp.36.5.539 · Cited by 530
The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells
Daniels‐Wells, T. R., Delgado, T., Helguera, G. F., & Penichet, M. L. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.06.006 · Cited by 519
Whitnall, M., Howard, J., Ponka, P., & Richardson, D. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604979103 · Cited by 515
Transcriptional control of granulocyte and monocyte development
Friedman, A. D. (2007) · Oncogene · doi:10.1038/sj.onc.1210764 · Cited by 427
Distinct mitochondrial retrograde signals control the G1-S cell cycle checkpoint
Owusu-Ansah, E., Yavari, A., Mandal, S., & Banerjee, U. K. (2008) · Nature Genetics · doi:10.1038/ng.2007.50 · Cited by 367
Cooperating gene mutations in acute myeloid leukemia: a review of the literature
Renneville, A., Roumier, C., Biggio, V., Nibourel, O., Boissel, N., Fenaux, P., & Preudhomme, C. (2008) · Leukemia · doi:10.1038/leu.2008.19 · Cited by 362
Self-citationGenetics of Myeloid Malignancies: Pathogenetic and Clinical Implications
Fröhling, S., Scholl, C., Gilliland, D. G., & Levine, R. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.010 · Cited by 356
Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation
Nasr, R., Guillemin, M.-C., Ferhi, O., Soilihi, H., Pérès, L., Berthier, C., Rousselot, P. H., Robledo-Sarmiento, M., Lallemand-Breitenbach, V., Gourmel, B., et al. (2008) · Nature Medicine · doi:10.1038/nm.1891 · Cited by 354
Transcriptional regulation of granulocyte and monocyte development
Friedman, A. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205324 · Cited by 333
Le, N. T. V., & Richardson, D. R. (2004) · Blood · doi:10.1182/blood-2004-05-1866 · Cited by 321
MafB Is an Interaction Partner and Repressor of Ets-1 That Inhibits Erythroid Differentiation
Sieweke, M. H., Tekotte, H., Frampton, J., & Graf, T. (1996) · Cell · doi:10.1016/s0092-8674(00)81081-8 · Cited by 302
Moura, I. C., Centelles, M. N., Arcos-Fajardo, M., Malheiros, D. M., Collawn, J. F., Cooper, M. D., & Monteiro, R. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.4.417 · Cited by 293
Self-citationIron trafficking in the mitochondrion: novel pathways revealed by disease
Napier, I. A., Ponka, P., & Richardson, D. R. (2004) · Blood · doi:10.1182/blood-2004-10-3856 · Cited by 291
The Molecular Basis of Leukemia
Gilliland, D. G., Jordan, C. T., & Felix, C. A. (2004) · Hematology · doi:10.1182/asheducation-2004.1.80 · Cited by 286
Rewired ERK-JNK Signaling Pathways in Melanoma
Lopez‐Bergami, P., Huang, C. C., Goydos, J. S., Yip, D., Bar‐Eli, M., Herlyn, M., Smalley, K. S. M., Mahale, A. M., Eroshkin, A. M., Aaronson, S. A., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.03.009 · Cited by 285
Transferrin and transferrin receptors in carcinoma of the breast
Page Faulk, W., Hsi, B.-L., & Stevens, P. J. (1980) · The Lancet · doi:10.1016/s0140-6736(80)90440-7 · Cited by 280
Trowbridge, I. S., & Domingo, D. L. (1981) · Nature · doi:10.1038/294171a0 · Cited by 275
Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents
Richardson, D. R., Kalinowski, D. S., Lau, S. L., Jansson, P. J., & Lovejoy, D. B. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.04.003 · Cited by 260
Hematopoietic Growth Factors Signal Through the Formation of Reactive Oxygen Species
Sattler, M., Winkler, T., Verma, S., Byrne, C. H., Shrikhande, G., Salgia, R., & Griffin, J. D. (1999) · Blood · doi:10.1182/blood.v93.9.2928 · Cited by 254
Heterozygous PU.1 mutations are associated with acute myeloid leukemia
Mueller, B. U., Pabst, T., Osato, M., Asou, N., Johansen, L. M., Minden, M. D., Behre, G., Hiddemann, W., Ito, Y., & Tenen, D. G. (2002) · Blood · doi:10.1182/blood.v100.3.998 · Cited by 243
A Review of Fluorescence Methods for Assessing Labile Iron in Cells and Biological Fluids
Espósito, B. P., Epsztejn, S., Breuer, W. V., & Cabantchik, Z. I. (2002) · Analytical Biochemistry · doi:10.1006/abio.2002.5611 · Cited by 241
Hp, K., AMATRUDA, T. T., IKEKAWA, N., Kobayashi, Y., & Hf, D. (1984) · PubMed · Cited by 230
Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation
Pullarkat, V. A., Blanchard, S., Tegtmeier, B., Dagis, A., Patané, K., Ito, J. I., & Forman, S. J. (2008) · Bone Marrow Transplantation · doi:10.1038/bmt.2008.262 · Cited by 207
Kansas, G., Muirhead, M., & Dailey, M. O. (1990) · Blood · doi:10.1182/blood.v76.12.2483.2483 · Cited by 204
Hmama, Z., Nandan, D., Sly, L. M., Knutson, K. L., Herrera-Velit, P., & Reiner, N. E. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.11.1583 · Cited by 176
Proteomic and Genetic Approaches Identify Syk as an AML Target
Hahn, C. K., Berchuck, J. E., Ross, K. N., Kakoza, R. M., Clauser, K. R., Schinzel, A. C., Ross, L. S., Galinsky, I. A., Davis, T. N., Silver, S. J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.08.018 · Cited by 172
A transcription factor party during blood cell differentiation
Sieweke, M. H., & Graf, T. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80009-9 · Cited by 164
Zhu, J., Lallemand-Breitenbach, V., & de Thé, H. (2001) · Oncogene · doi:10.1038/sj.onc.1204852 · Cited by 151
Richardson, D. R., Poňka, P., & Baker, E. (1994) · PubMed · Cited by 139
Fu, D., & Richardson, D. R. (2007) · Blood · doi:10.1182/blood-2007-03-076737 · Cited by 131
Ricciardi, M. R., McQueen, T. J., Chism, D. D., Milella, M., Estey, E. H., Kaldjian, E. P., Sebolt, J. S., Konopleva, M. Y., & Andreeff, M. (2005) · Leukemia · doi:10.1038/sj.leu.2403859 · Cited by 125
Chaston, T. B., Watts, R., Yuan, J. J., & Richardson, D. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0865 · Cited by 120
The JNK Are Important for Development and Survival of Macrophages
Himes, S. R., Sester, D. P., Ravasi, T., Cronau, S. L., Sasmono, T., & Hume, D. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2219 · Cited by 117 · cited 1×
“Given the high similarities shared between VD and iron deprivation agents to induce cell differentiation, we investi gated whether iron deprivation of cells could induce VDR signaling (Wang et al., 2003; Himes et al., 2006).”
BackgroundMoura, I. C. (2004) · Blood · doi:10.1182/blood-2003-07-2440 · Cited by 114
Self-citationObjectives of iron chelation therapy in myelodysplastic syndromes: more than meets the eye?
Pullarkat, V. A. (2009) · Blood · doi:10.1182/blood-2009-07-234062 · Cited by 108
Jurutka, P. W., Hsieh, J., Nakajima, S., Haussler, C. A., Whitfield, G. K., & Haussler, M. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3519 · Cited by 104
Ji, Y., & Studzinski, G. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3029 · Cited by 95
Progress in the treatment of acute myeloid leukemia
Ravandi, F., Burnett, A. K., Agura, E. D., & Kantarjian, H. M. (2007) · Cancer · doi:10.1002/cncr.23000 · Cited by 80
Taghon, T., Stolz, F., Smedt, M. D., Cnockaert, M., Verhasselt, B., Plum, J. R., & Leclercq, G. (2002) · Blood · doi:10.1182/blood.v99.4.1197 · Cited by 70
Vitamin D3-driven signals for myeloid cell differentiation—Implications for differentiation therapy
Hughes, P., Marcinkowska, E., Gocek, E., Studzinski, G. P., & Brown, G. (2009) · Leukemia Research · doi:10.1016/j.leukres.2009.09.010 · Cited by 67
Callens, C., Moura, I. C., Lepelletier, Y., Coulon, S., Renand, A., Dussiot, M., Ghez, D., Benhamou, M., Monteiro, R. C., Bazarbachi, A. A., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404958 · Cited by 62
Self-citationThe relationship of erythropoietin and iron metabolism to red blood cell production in humans.
Adamson, J. W. (1994) · PubMed · Cited by 59
Structure and function of transferrin receptors and their relationship to cell growth.
Trowbridge, I. S., & Shackelford, D. A. (1986) · PubMed · Cited by 58
Wang, Q., Wang, X., & Studzinski, G. P. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10595 · Cited by 54
Signal Transduction by MAP Kinases: Regulation by Phosphorylation-Dependent Switches
Whitmarsh, A. J., & Davis, R. J. (1999) · Science s STKE · doi:10.1126/stke.1999.1.pe1 · Cited by 52
Amir-Moazami, O., Alexia, C., Charles, N., Launay, P., Monteiro, R. C., & Benhamou, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705320200 · Cited by 45
Self-citationBastie, J.-N., Balitrand, N., Guidez, F., Guillemot, I., Larghero, J., Calabresse, C., Chomienne, C., & Delva, L. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0412 · Cited by 44
Lepelletier, Y., Camara‐Clayette, V., Jin, H., Hermant, A., Coulon, S., Dussiot, M., Arcos‐Fajardo, M., Baude, C., Canionni, D., Delarue, R., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1962 · Cited by 39
Self-citationBoehrer, S., Adès, L., Galluzzi, L., Tajeddine, N., Tailler, M., Gardin, C., de Botton, S., Fenaux, P., & Kroemer, G. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.05.024 · Cited by 36
Methods for Studying Signal‐Dependent Regulation of Translation Factor Activity
Wang, X., & Proud, C. G. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)31007-0 · Cited by 35
Vitamin D2 analog (Paricalcitol; Zemplar) for treatment of myelodysplastic syndrome
Koeffler, H. P., Aslanian, N., & O’Kelly, J. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.04.003 · Cited by 35
Gemelli, C., Orlandi, C., Zanocco‐Marani, T., Martello, A., Vignudelli, T., Ferrari, F., Montanari, M., Parenti, S., Testa, A., Grande, A., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5660 · Cited by 30
Lim, B., McArdle, H. J., & Morgan, E. H. (1987) · Journal of Comparative Physiology B · doi:10.1007/bf00693363 · Cited by 30
Ferrero, D., Campa, E., Dellacasa, C. M., Campana, S., Foli, C., & Boccadoro, M. (2004) · PubMed · Cited by 29
Iron signaling and oxidant damage
Kalyanaraman, B. (2007) · Cardiovascular Toxicology · doi:10.1007/s12012-007-0025-1 · Cited by 22
Roumier, C., Lejeune‐Dumoulin, S., Renneville, A., Goethgeluck, A. S., Philippe, N., Fenaux, P., & Preudhomme, C. (2006) · Leukemia · doi:10.1038/sj.leu.2404097 · Cited by 19
Srivastava, M. D., & Ambrus, J. L. (2004) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819032000159924 · Cited by 17
FENTON, R. H., Johnson, F. B., & Zimmerman, L. E. (1964) · Journal of Histochemistry & Cytochemistry · doi:10.1177/12.3.153 · Cited by 12
1α, 25‐Dihydroxy‐vitamin D3 alters syk activation through FcγRII in monocytic THP‐1 cells
Agramonte‐Hevia, J., Hallal, C., Garay-Canales, C. A., Guerra‐Araiza, C., Camacho‐Arroyo, I., & Ortega, E. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10575 · Cited by 6
Retinoic acid and acute promyelocytic leukemia: a model of targetting treatment for human cancer.
Chen, Z., Chen, S., & Wang, Z. (1994) · PubMed · Cited by 5
Flagged first, then by citations
Cited by
Sorted by citations
IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics
Sasaki, M., Knobbe, C. B., Munger, J. C., Lind, E. F., Brenner, D., Brüstle, A., Harris, I. S., Holmes, R., Wakeham, A., Haight, J., et al. (2012) · Nature · doi:10.1038/nature11323 · Cited by 513
Differentiation therapy revisited
de Thé, H. (2018) · Nature reviews. Cancer · doi:10.1038/nrc.2017.103 · Cited by 462
PML/RARA Oxidation and Arsenic Binding Initiate the Antileukemia Response of As2O3
Jeanne, M., Lallemand-Breitenbach, V., Ferhi, O., Koken, M. H. M., Bras, M. L., Duffort, S., Pérès, L., Berthier, C., Soilihi, H., Raught, B., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.06.003 · Cited by 332
Inhibition of Endosteal Vascular Niche Remodeling Rescues Hematopoietic Stem Cell Loss in AML
Duarte, D., Hawkins, E. D., Akinduro, O., Ang, H. Y.-K., Filippo, K. D., Kong, I. Y., Haltalli, M. L. R., Ruivo, N., Straszkowski, L., Vervoort, S. J., et al. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.11.006 · Cited by 328
Satoh‐Takayama, N., Lesjean‐Pottier, S., Vieira, P., Sawa, S., Eberl, G., Vosshenrich, C. A. J., & Santo, J. P. D. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20092029 · Cited by 307
Metadata
- Authors
- Callens, C., Coulon, S., Naudin, J., Radford-Weiss, I., Boissel, N., Raffoux, E., Wang, P. H. M., Agarwal, S., Tamouza, H., Paubelle, E., Asnafi, V., Ribeil, J.-A., Dessen, P., Canioni, D., Chandesris, O., Rubio, M. T., Beaumont, C., Benhamou, M., Dombret, H., Macintyre, E., Monteiro, R. C., Moura, I. C., & Hermine, O.
- Affiliations
- Centre National de la Recherche Scientifique UMR 8147, Paris 75015, France 1
- Centre National de la Recherche Scientifique (FR)
- Faculté de Médecine, Université René Descartes Paris V, Institut Fédératif Necker, Paris 75015, France 2
- Assistance Publique – Hôpitaux de Paris (FR)
- Inserm (FR)
- Hôpital Necker-Enfants Malades (FR)
- Institut Gustave Roussy (FR)
- Corresponding author
- Hermine, Olivier
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2010-04-05
- Volume
- 207
- Issue
- 4
- Pages
- 731-750
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2856037
- OpenAlex
- W2137774959
- Cited by
- 197
- References
- 76
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 5 · 2023: 14 · 2022: 11 · 2021: 15 · 2020: 13 · 2019: 9 · 2018: 13 · 2017: 12 · 2016: 11 · 2015: 13 · 2014: 13 · 2013: 9 · 2012: 20
- FWCI
- 11.44
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Institut National de la Santé et de la Recherche Médicale
- Fondation pour la Recherche Médicale
- Fondation de France
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- acute myeloid leukemia, iron homeostasis, iron chelation, iron starvation, cell differentiation, vitamin D3, vitamin D receptor, reactive oxygen species, monocyte-to-macrophage differentiation, pancytopenia, combination therapy, refractory leukemia
- MeSH terms
- Iron Deficiencies, Aged, Animals, Antibodies, Monoclonal, Blood Cell Count, Cell Differentiation, Cholecalciferol, Drug Synergism, Female, Granulocytes, Hematopoietic Stem Cells, Homeostasis, Humans, Hydroxycholecalciferols, Iron, Iron Chelating Agents, Male, Mice, Nude, Monocytes, Phosphorylation, Receptors, Transferrin, Leukemia, Myeloid, Acute, Antigens, CD, Gene Expression, Apoptosis, Reactive Oxygen Species, Receptors, Calcitriol, Lipopolysaccharide Receptors, Gene Expression Profiling, Mitogen-Activated Protein Kinases, Xenograft Model Antitumor Assays, CD11b Antigen, Cell Line, Tumor, JNK Mitogen-Activated Protein Kinases, Cell Proliferation, Mice, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
